Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Overview Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Therapeutics Development Products under Development by Stage of Development Products under Development by Therapy Area Products under Development by Indication Products under Development by Companies Products under Development by Universities/Institutes Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Therapeutics Assessment Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Companies Involved in Therapeutics Development AbbVie Inc Advenchen Laboratories LLC Aeterna Zentaris Inc Amgen Inc AstraZeneca Plc Chipscreen Biosciences Ltd Cielo Therapeutics Inc Sanofi Sareum Holdings Plc Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Drug Profiles AL-8326 - Drug Profile Product Description Mechanism Of Action R&D Progress AMG-900 - Drug Profile Product Description Mechanism Of Action R&D Progress AZD-2811 - Drug Profile Product Description Mechanism Of Action R&D Progress CS-2164 - Drug Profile Product Description Mechanism Of Action R&D Progress danusertib - Drug Profile Product Description Mechanism Of Action R&D Progress DBPR-114 - Drug Profile Product Description Mechanism Of Action R&D Progress ilorasertib - Drug Profile Product Description Mechanism Of Action R&D Progress NMI-900 - Drug Profile Product Description Mechanism Of Action R&D Progress SAR-156497 - Drug Profile Product Description Mechanism Of Action R&D Progress SAR-3 - Drug Profile Product Description Mechanism Of Action R&D Progress SAR-4 - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules to Inhibit Aurora B Kinase and ERK2 for Oncology - Drug Profile Product Description Mechanism Of Action R&D Progress TY-011 - Drug Profile Product Description Mechanism Of Action R&D Progress Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Prot

List of Tables Number of Products under Development by Stage of Development, H1 2018 Number of Products under Development by Therapy Areas, H1 2018 Number of Products under Development by Indications, H1 2018 Number of Products under Development by Indications, H1 2018 (Contd..1), H1 2018 Number of Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 (Contd..1), H1 2018 Products under Development by Companies, H1 2018 (Contd..2), H1 2018 Number of Products under Investigation by Universities/Institutes, H1 2018 Products under Investigation by Universities/Institutes, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Pipeline by AbbVie Inc, H1 2018 Pipeline by Advenchen Laboratories LLC, H1 2018 Pipeline by Aeterna Zentaris Inc, H1 2018 Pipeline by Amgen Inc, H1 2018 Pipeline by AstraZeneca Plc, H1 2018 Pipeline by Chipscreen Biosciences Ltd, H1 2018 Pipeline by Cielo Therapeutics Inc, H1 2018 Pipeline by Sanofi, H1 2018 Pipeline by Sareum Holdings Plc, H1 2018 Dormant Products, H1 2018 Dormant Products, H1 2018 (Contd..1), H1 2018 Dormant Products, H1 2018 (Contd..2), H1 2018 Dormant Products, H1 2018 (Contd..3), H1 2018 Dormant Products, H1 2018 (Contd..4), H1 2018 Discontinued Products, H1 2018 Discontinued Products, H1 2018 (Contd..1), H1 2018 List of Figures Number of Products under Development by Stage of Development, H1 2018 Number of Products under Development by Top 10 Indications, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018

AbbVie Inc Advenchen Laboratories LLC Aeterna Zentaris Inc Amgen Inc AstraZeneca Plc Chipscreen Biosciences Ltd Cielo Therapeutics Inc Sanofi Sareum Holdings Plc